On September 1, 2017, the Food and Drug Administration (FDA or the Agency) released a final guidance document discussing the procedures for Medical Device Advisory Committee meetings (or, panel meetings). The document, entitled Procedures for Meetings of the Medical Devices Advisory Committee (final guidance), follows an April 2015 draft guidance and supersedes two much older guidance documents on Amended Procedures for Advisory Panel Meetings (July 22, 2000) and the Panel Review of Premarket Approval Applications #P91-2 blue book memorandum (May 3, 1991).
Please see full publication below for more information.